Company Search:
Advanced Search
Sponsored Links
Sopharma Properties ADSITS Company Snapshot
Sopharma Properties ADSITS operates in the Apartment building operators sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sopharma Properties ADSITS with three other Real estate operators in Europe: SBF Bostad AB (publ) of SWEDEN (2019 sales of 58.73 million Swedish Kronor [US$7.00 million] ), SM Wirtschaftsberatungs AG of GERMANY (6.42 million Euros [US$7.76 million] ), and Immo Beaulieu NV which is based in BELGIUM (6.19 million Euros [US$7.48 million] ).

Sales Analysis. Sopharma Properties ADSITS reported sales of 11.61 million Bulgarian Levas (US$7.17 million) for the year ending December of 2019. This represents an increase of 3.9% versus 2018, when the company's sales were 11.18 million Bulgarian Levas. This was the third consecutive year of growth at Sopharma Properties ADSITS.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Sopharma Properties ADSITS
  Stock Performance Chart for Sopharma Properties ADSITS
  Stock Data: Recent Stock Performance:
  Current Price (1/15/2021): 5.50
(Figures in Bulgarian Levas)
1 Week -2.7%   13 Weeks -1.8%  
4 Weeks -1.8%   52 Weeks -16.0%  
Sopharma Properties ADSITS Key Data:
  Ticker: 6S6 Country: Bulgaria
  Exchanges: BGR Major Industry: Real Estate
    Sub Industry: Apartment Building Operators
  2019 Sales 11,614,000
(Year Ending Jan 2020).
Employees: N/A
  Currency: Bulgarian Levas Market Cap: 117,787,604
  Fiscal Yr Ends: December Shares Outstanding: 21,415,928
  Share Type: Closely Held Shares: 16,584,521
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.